DekaLux-BioTech CF |
Growth Of 1000 (EUR) | 30/04/2024 |
|
Annual Returns (EUR) | 30/04/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |
Total Return | 6.36 | -10.42 | 34.61 | 14.94 | 7.25 | -7.22 | 1.35 | -2.13 |
+/- Category | 0.30 | -1.44 | 7.28 | -4.31 | 10.28 | 5.57 | 0.27 | 0.17 |
+/- Category Index | -4.41 | -7.48 | 10.98 | -10.90 | 0.33 | -4.18 | -8.55 | -10.14 |
% Rank in Category | 56 | 71 | 18 | 43 | 25 | 54 | 41 | 59 |
Trailing Returns (EUR) | 02/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.96 | -0.94 | 0.86 |
1 Week | 2.06 | -2.25 | -0.86 |
1 Month | -3.27 | -0.36 | -3.85 |
3 Months | -2.67 | -3.97 | -8.11 |
6 Months | 11.95 | -4.17 | -3.84 |
YTD | -1.19 | -1.07 | -10.11 |
1 Year | 2.63 | -1.43 | -13.92 |
3 Years Annualised | -0.99 | 4.36 | -8.64 |
5 Years Annualised | 6.11 | -0.35 | -6.16 |
10 Years Annualised | 7.88 | -1.18 | -3.42 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (EUR) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 2.55 | - | - | - |
2023 | -5.46 | 0.27 | -0.19 | 7.11 |
2022 | -11.34 | -2.75 | 5.28 | 2.20 |
2021 | -0.11 | 9.72 | 1.14 | -3.24 |
2020 | -8.67 | 20.83 | -4.24 | 8.75 |
2019 | 18.88 | -2.78 | -4.12 | 21.47 |
Advertisement |